A focus on homelessness as VA and UAB researchers mark National VA Research Week
Written by Jeff Hansen
VA Research support for UAB clinicians and scientists has been important for six decades.
UAB joins national research partnership to innovate health care education, delivery
Written by UAB Reporter
UAB is one of 18 sites in a national network to advance interprofessional practice and education through simulation.
Longtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.
Faculty ombudsperson candidate sessions planned for May 10-13
Written by UAB Heersink School of Medicine News
Faculty are invited to attend sessions for the UAB ombudsperson candidates planned for next week.
The UAB GBS/JHS Graduate Research Student Research Symposium is Friday, May 13 in the UAB Hill Student Center. Keynote speaker is geneticist Neil Risch, Ph.D.
Faculty and staff in the Department of Medical Education have restructured the process of accepting international medical students for clinical electives at UAB.
Applications open for 2016 General Endowment Fund awards
Written by UAB Heersink School of Medicine News
The Health Services Foundation General Endowment Fund grants offer financial support for projects within UAB demonstrating multidisciplinary efforts in clinical care, medical education, laboratory research and patient-oriented research.
Division of Congenital Cardiac Anesthesiology established in the Department of Anesthesiology
Written by Julie Cole Miller
The Department of Anesthesiology and Perioperative Medicine is pleased to announce the establishment of the Division of Congenital Cardiac Anesthesiology.
Two young Alabama women formed a bond over a rare germ cell cancer affecting only 1,000 women across the United States.
Parkinson’s disease pathogenesis is reduced in a rat model using a cell-signaling inhibitor drug
Written by Jeff Hansen
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.